Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002541041 | SCV002957278 | uncertain significance | not provided | 2022-05-03 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 1320030). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCA1 protein function. This variant has not been reported in the literature in individuals affected with ABCA1-related conditions. This variant is present in population databases (rs759576379, gnomAD 0.03%). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 672 of the ABCA1 protein (p.Arg672Trp). |
Phenosystems SA | RCV001775207 | SCV002011872 | likely pathogenic | Reduced delayed hypersensitivity | no assertion criteria provided | clinical testing | ||
Phenosystems SA | RCV001775208 | SCV002012362 | likely pathogenic | Symphalangism affecting the proximal phalanx of the 4th finger | no assertion criteria provided | clinical testing | ||
Phenosystems SA | RCV001777124 | SCV002014579 | likely pathogenic | Breast carcinoma | no assertion criteria provided | clinical testing |